NorthStar to provide Cellectar with non-carrier-added Ac-225 for its expanded portfolio of clinical programsFLORHAM PARK, N.J., Nov. 14, 2024 ...

Using analysis from an open-label, long-term treatment study of the RNS ® System, Rapport will present key new data on the correlation between the reduction in long episode (LE) frequency (abnormal ...

Hoth Therapeutics shares rose after the company reported favorable early data from a preclinical study of cancer drug HT-KIT. The stock was up 34% to $1.18 Tuesday and is down about 18% this year.

“We are thrilled to present preclinical data for ZW220 and ZW251 at the EORTC ... The Company’s complementary therapeutic platforms and fully integrated drug development engine provide the flexibility ...

“We are thrilled to present preclinical ... new drug application (IND) and non-U.S. applications for ZW220 in the first half of 2025. Zymeworks is a global clinical-stage biotechnology company ...

Federal officials have celebrated a striking drop in drug overdoses across the country ... according to new federal data, a major development in the nation’s efforts to combat the effects ...

Presentations highlight key preclinical data that support investigational new ... The Company’s complementary therapeutic platforms and fully integrated drug development engine provide the flexibility ...